Paraganglioma, Extra-Adrenal

Explore clinical trials studying Paraganglioma, Extra-Adrenal. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Paraganglioma, Extra-Adrenal trial results

Completed

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

NCT04860700

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Neoplasm Metastasis, +14 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

NCT02592356

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

NCT03008369

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

The Efficacy and Safety of Temozolomide in Patients With MPPGL

NCT05858177

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT01155258

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +115 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid

NCT01152827

Conditions: Extra-adrenal Paraganglioma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

NCT01076530

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +67 more
Locations: Childrens Memorial Hospital Chicago, Illinois, United States

C S Mott Children's Hospital Ann Arbor, Michigan, United States

University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States

Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Paraganglioma, Extra-Adrenal

Paraganglioma, Extra-Adrenal trial results

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

The Efficacy and Safety of Temozolomide in Patients With MPPGL

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Related conditions